Popular Articles
Burdock Root

Rigel's R788 Evaluated In Phase 2 Trial In Multiple Cancers
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that its oral Syk inhibitor, R788, is being evaluated in a Phase 2 clinical trial funded, designed and implemented by the National Cancer Institute (NCI), part of the U.S. National Institutes of Health. This open-label, single arm clinical trial will include patients with advanced colorectal, thyroid, non-small cell lung, hepatocellular, head and neck, or renal cell cancers who have failed to respond to at least one line of therapy.
generic viagra online
Social Class, Gender And Ethnic Group Determine Adolescents' Sexual-Affective Education
The social class, the gender and the ethnic group are three essential dimensions, not only in the social differentiation, but also in the affective sexual education of the adolescents, where it is necessary to take part in order to promote sexual and gender equity and prevent gender violence. This is one of the main conclusions of the investigation Affective sexual policy: a sociological approach to affective sexual education", carried out by the researcher of the department of Sociology of the University of Granada Mar Venegas Medina and supervised by professor Francisco Fernández Palomares.
News of the day
Echo Therapeutics To Present At Prestigious 'Innovations In Diabetes' Conference
Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE), a diabetes management company developing the needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system, announced that Patrick T. Mooney, M.D., Chairman and Chief Executive Officer, will present at the "Innovations in Diabetes" Conference on, Tuesday, July 14, 2009 at 5:30 pm ET. The presentation will occur live and will be held at The Pier V Hotel at the Inner Harbor in Baltimore.
Medical Devices

What Is Polio (poliomyelitis)? What Causes Polio?

Polio, or poliomyelitis, is a highly contagious viral infection that can lead to paralysis, breathing problems, or even death. The term poliomyelitis is from the Greek poliÃös meaning "grey", myelÃös referencing the spinal cord, and -itis meaning inflammation. Polio can be classified as either symptomatic or asymptomatic. About 95% of all cases display no symptoms (asymptomatic polio), and between 4% and 8% of cases display symptoms (symptomatic polio). Symptomatic polio can be broken down further into a mild form called nonparalytic or abortive polio and a severe form called paralytic polio (occurring in 0.1% to 2% of cases). Paralytic polio also may be classified as: *Spinal polio - attacks motor neurons in the spinal cord and causes paralysis in arms and legs and breathing problems *Bulbar polio - affects neurons responsible for sight, vision, taste, swallowing, and breathing *Bulbospinal polio - both spinal and bulbar polio Many people with nonparalytic polio are able to make a full recovery, while those with paralytic polio generally end up with permanent paralysis. Who gets polio? Like many other infectious diseases, polio victims tend to be some of the most vulnerable members of the population. This includes the very young, pregnant women, and those with immune systems that are substantially weakened by other medical conditions. Anyone who has not been immunized against polio is especially susceptible to contracting the infection. Additional risk factors for polio include traveling to places where polio is endemic or widespread, living with someone infected with polio, working in a laboratory where live poliovirus is kept, and having your tonsils removed. What causes polio? Polio is caused by the poliovirus, a highly contagious virus specific to humans. The virus usually enters the environment in the feces of someone who is infected. In areas with poor sanitation, the virus easily spreads through the fecal-oral route, via contaminated water or food. In addition, direct contact with a person infected with the virus can cause polio. What are the symptoms of polio? Polio, in its most debilitating forms, displays symptoms such as paralysis and death. However, most people with polio don"t actually display any symptoms or become noticeably sick. When symptoms do appear, there are differences depending on the type of polio. Nonparalytic polio (abortive poliomyelitis) leads to flu-like symptoms that last for a few days or weeks, such as fever, sore throat, headache, vomiting, fatigue, back and neck pain, arm and leg stiffness, muscle tenderness, muscle spasms, and meningitis. Paralytic polio will often begin with symptoms similar to nonparalytic polio, but will progress to more serious symptoms such as a loss of muscle reflexes, severe muscle pain and spasms, and loose or floppy limbs that is often worse on one side of the body. How is polio diagnosed? Polio is often recognized because of symptoms such as neck and back stiffness, abnormal reflexes, and trouble with swallowing and breathing. A physician who suspects polio will perform laboratory tests that check for poliovirus using throat secretions, stool samples, or cerebrospinal fluid. How is polio treated? There is no cure for polio once a person becomes infected. Therefore, treatments are focused on increasing comfort, managing symptoms, and preventing complications. This may include providing bed rest, antibiotics for additional infections, pain killers, ventilators to help breathing, physiotherapy and moderate exercise, and a proper diet. One treatment for lung paralysis due to polio was to place the patient into an iron lung - a device that would push and pull chest muscles to make them work. However, more modern portable ventilators and jacket-type ventilators are now employed. How can polio be prevented? Although polio essentially has been eradicated in the US since 1979 and in the Western Hemisphere since 1991, children and adults in Afghanistan, India, Nigeria, and Pakistan are still contending with the disease. There are two vaccines available to fight polio - inactivated poliovirus (IPV) and oral polio vaccine (OPV). IPV, which consists of a series of injections beginning two months after birth and continuing until a child is 4 to 6 years old, is provided to most children in the United States. The vaccine is created from inactive poliovirus, but it is very safe and effective and cannot cause polio. OPV is created from a weakened or attenuated form of poliovirus, and it is the vaccine of choice in many countries because of its low cost, ease of administration, and ability to provide excellent immunity in the intestine. OPV, however, has been known to revert to a dangerous form of poliovirus that is able to paralyze its victim. Polio vaccinations or boosters are highly recommended in anyone who is not vaccinated or is unsure if she is vaccinated. Written by Peter Crosta M.A. Copyright: Medical News Today Not to be reproduced without permission of Medical News Today


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):